Since the PRLR/PRL axis has been implicated in other tissues, including reproductive tissues and prostate [9, 27–31], h16f-MMAE and ABBV-176 conjugates were evaluated for their ability to inhibit the growth of non-breast-derived tumor cell lines (Table 1). Here, PRL is linked to neoplasm.